Karl G. WassmannPresident & CEO

Karl G. Wassmann is a pioneer in the molecular diagnostic industry for the development and commercialization of blood-based cancer diagnostic tests, including early detection, prognostic and immuno-oncology predictive response tests. During his 40 year business career, Mr. Wassmann has worked in both the life sciences and high-performance computing fields. Read more


Alan M. Christenfeld, Chairman, Secretary & Treasurer

For nearly 40 years, Alan M. Christenfeld has been a trusted business and legal advisor to commercial businesses, financial institutions and other enterprises in connection with business formation and planning; debt and equity capital raises; acquisitions and divestitures; dispute avoidance and resolution; financial and business restructurings; and other core strategic matters. Read more


William OhWilliam K. Oh, MD, Chief Scientific Officer and Chairman of the Science Advisory Board

Dr. William Oh is the Chief of the Division of Hematology and Medical Oncology at Mount Sinai Hospital in New York City; Professor of Medicine and Urology and Ezra M. Greenspan Professor in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai; and Associate Director for Clinical Research at The Tisch Cancer Institute at Mount Sinai. Read more